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Abstract We show that Cibacron Blue F3GA dye resin
chromatography can be used to identify ligands that spe-
ciﬁcally interact with proteins from Mycobacterium tuber-
culosis, and that the identiﬁcation of these ligands can
facilitatestructuredeterminationbyenhancingthequalityof
crystals. Four native Mtb proteins of the aldehyde dehy-
drogenase (ALDH) family were previously shown to be
speciﬁcally eluted from a Cibacron Blue F3GA dye resin
with nucleosides. In this study we characterized the nucle-
oside-binding speciﬁcity of one of these ALDH isozymes
(recombinant Mtb Rv0223c) and compared these biochem-
ical results with co-crystallization experiments with differ-
ent Rv0223c-nucleoside pairings. We found that the
strongly interacting ligands (NAD and NADH) aided for-
mation of high-quality crystals, permitting solution of the
ﬁrst Mtb ALDH (Rv0223c) structure. Other nucleoside
ligands (AMP, FAD, adenosine, GTP and NADP) exhibited
weaker binding to Rv0223c, and produced co-crystals dif-
fracting to lower resolution. Difference electron density
maps based on crystals of Rv0223c with various nucleoside
ligands show most share the binding site where the natural
ligand NAD binds. From the high degree of similarity of
sequence and structure compared to human mitochondrial
ALDH-2 (BLAST Z-score = 53.5 and RMSD = 1.5 A ˚),
Rv0223c appears to belong to the ALDH-2 class. An altered
oligomerization domain in the Rv0223c structure seems to
keepthisproteinasmonomerwhereasnativehumanALDH-
2 is a multimer.
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FMN Flavin mononucleotide
NMN Nicotinamide mononucleotide
GTP Guanosine-50-triphosphate
IPTG Isopropyl-b-D-thiogalactoside
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Introduction
Nucleosides and their derivatives in cellular metabolism are
well recognized asenergycarriers inmetabolictransactions,
essential chemical links for intracellular signals, and con-
stituents of nucleic acids (DNA and RNA) [1, 2]. The
metabolism of nucleosides is vital to a cell’s survival, and
about half of all enzymes are nucleoside-dependent, repre-
senting one of the largest and most important classes of
cellular proteins [3]. Determining structure–function rela-
tionships of nucleoside-binding proteins is therefore a sig-
niﬁcant component of the structural genomics of proteins
that are crucial to cell function. Two major challenges in
suchstudiesarethesigniﬁcantnumberoftargetproteins,and
the problem ofsortingproteinsaccordingtotheir nucleoside
speciﬁcity.
Nucleoside ligand-binding to individual proteins typi-
cally occurs with high speciﬁcity, and is often sensitive to
slight changes at the protein interaction site [4–6]. Eluci-
dating speciﬁc interactions between ligands and proteins
helps to derive functional insights for many proteins [7, 8],
complementing bioinformatics approaches, and may pro-
vide the sole source of functional information for hypo-
thetical proteins.
The aldehyde dehydrogenases (ALDH) comprise a large
family of proteins which metabolize various endogenous
and exogenous substrates [9, 10]. The human genome con-
tains19putativeALDHgenesandthreepseudogenes.Many
of them are regulated in response to oxidative stress and
over expressed in various tumors [11, 12]. ALDH enzymes
have multiple catalytic and non-catalytic functions in ester
hydrolysis, antioxidant properties, xenobiotic bioactivation
and UV light absorption, and also play important roles in
embryogenesis, development and neurotransmission [13,
14].Mutationsinthesegenescausesubsequentinbornerrors
in aldehyde metabolism, such as Sjo ¨gren-Larsson syndrome
[15], Type II hyperprolinaemia and gamma-hydroxybutyric
aciduria [16], and pyridoxine-dependent seizures [17].
Human ALDH-2 is important as a nitroglycerin reductase
[18] and an activator of NADPH oxidases [9], and for the
major function of elimination of toxic aldehydes which lead
to lipid peroxidation, protein/enzyme dysfunction, struc-
tural damage and apoptosis inalcoholrelated disorders [19],
such as alcohol liver disease [20], heart disease [21] and
gastrointestinal cancer [22].
The Mycobacterium tuberculosis (Mtb) genome encodes
ten putative ALDH proteins potentially associated with
seven different ALDH classes (Table 1), suggesting that
they have diversity comparable to human ALDHs [13, 14].
The presence of a Rossman consensus sequence [23] in four
of ten predicted Mtb ALDHs (Table 1) further suggests
diversity at the level of nucleotide binding at the cofactor
binding site.
In a previous report, we used dye-ligand elution chro-
matography to screen for nucleoside-binding proteins in
Mtb cell extracts and to analyze the speciﬁcity of nucleo-
side-protein interactions [24]. That study identiﬁed 26
native Mtb proteins binding to Cibacron Blue resin that
were speciﬁcally eluted with nucleosides. Four of these 26
proteins were members of the ALDH family, as shown in
Table 1. The large number of ALDH proteins in the rela-
tively small Mtb genome, and the many essential functions
of ALDH proteins in human cells, suggest potential critical
roles of Mtb ALDHs for survival in its human host
environment.
In this report, we purify one of these Mtb ALDHs
(Rv0223c), characterize its nucleoside speciﬁcity, use
ligands that interact with Rv0223c to improve its crystal-
lization, present the ﬁrst structure of an Mtb ALDH, and
show its close structural similarity to human mitochondrial
ALDH-2.
Materials and methods
Cloning and expression of putative Mtb ALDHs
Four Mtb ALDH genes (Rv0223c, Rv0458, Rv2858c, and
Rv3293) were previously identiﬁed as interacting with
nucleosides using dye-resin chromatography and ligand-
speciﬁc elution [24]. Each targeted ALDH gene was
ampliﬁed by PCR from a M. tuberculosis H37Rv COSMID
library as the template with Pfu proof-reading DNA poly-
merase (Stratagene), using the 50 NdeI primer, 50-AGA-
TATACATATG ? (N-terminal 21 bases of target
sequence)-30, and the 30 BamHI primer, 50-AATTCG-
GATCC ? (C-terminal 23 bases of target sequence)-30.
The underlined bases represent the NdeI and BamHI sites,
respectively. The PCR amplicon was digested with NdeI
and BamHI restriction endonucleases (NEB), and cleaned
using Qiaquick PCR spin column (Qiagen). The product
was ligated into a modiﬁed pET-28 vector containing a C-
terminal 6-His tag, in frame with the BamHI restriction site
using T4 DNA ligase (New England BioLabs), and trans-
formed into BL21(DE3) (Novagen). The expressed pro-
teins contained the C-terminal tag GSHHHHHH, where GS
is encoded by the BamHI restriction site (GGATCC).
BL21(DE3) 3 ml cell culture was tested for the expression
of heterologous protein by binding on a Cobalt-chelated
Talon superﬂow bead slurry (Clontech) and SDS–PAGE
analysis.
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123Cell culture was performed as described by Studier [25]
with some modiﬁcations. Transformed cells were inocu-
lated into 3 ml seed culture media (1 mM MgSO4, 0.5%
glucose, 17 amino acids of 100 lg/ml for each Na-Glu,
Asp, Lys-HCl, Arg-HCl, His-HCl, Ala, Pro, Gly, Thr, Ser,
Gln, Asn, Val, Leu, Ile Phe, Trp, metal mix of 50 lM Fe,
20 lMC a ,1 0lM Mn, 10 lM Zn, 2 lM for each Co, Cu,
Ni, Mo, Se and B, 5 mM PO4, 5 mM Na, 2.5 mM K,
2.5 mM NH4 and 1.25 mM SO4), and grown overnight at
37C. From the seed culture, 500 ll was inoculated into
500 ml auto-induction media, containing 1 mM MgSO4,
metal mix (same as seed culture), 0.5% glycerol, 0.5%
glucose, 0.2% a-lactose, NPS (same as seed culture), and
35 lg/ml kanamycin. After cells were grown at 37C until
OD600 reaches 0.5, the growth was continued at 20C for
approximately 16 h until the OD600 reached approximately
15. The cells were harvested and stored at -80C.
The cell pellet was lysed by sonication in 10 ml of
buffer A (20 mM Tris–HCl, pH 8.0, and 100 mM NaCl)
per gram of cells for 10 min in 30 s pulses at 10C. The
cell debris was removed by ultra-centrifugation for 30 min
at 38,000 rpm using a Ti 60 rotor (Beckman). The clear
supernatant was ﬁltered through a 0.45 lm pore membrane
and loaded on a 5 ml Talon superﬂow afﬁnity column
equilibrated with buffer A. After washing with 30 ml
buffer A and 20 ml buffer B (20 mM Tris–HCl, pH 8.0,
100 mM NaCl and 20 mM imidazole), the His-tagged
Rv0223c (and the other ALDHs) was eluted from the
cobalt afﬁnity column using Buffer C (20 mM Tris–HCl,
pH 8.0, 100 mM NaCl and 300 mM imidazole). The eluted
fraction was dialyzed against Buffer D (20 mM Tris–HCl,
pH 8.0, 100 mM NaCl and 10 mM b-mercaptoethanol) and
puriﬁed by gel ﬁltration on a Superdex-75 column (GE
Healthcare Inc.) using Buffer D for equilibration and elu-
tion. The peak fractions (monitored at OD280) were ana-
lyzed by SDS–PAGE and the pooled protein fractions were
concentrated using a Centricon Plus-20 (Millipore) up to
35 mg/ml, which was measured by Bradford assay with
IgG (Bio-Rad) as a standard. The purity of each protein
was estimated to be higher than 95% based on densitom-
etry of SDS–PAGE gels [26].
Screening of Rv0223c for interactions with multiple
nucleosides and nucleotides
Recombinant proteins were evaluated for their ligand-
binding properties using a modiﬁed afﬁnity elution chro-
matography protocol [27]. Individual proteins were diluted
to 2 mg/ml in column buffer (CB, containing 50 mM
potassium phosphate, pH 7.5, 1 mM MgCl2 and 2 mM
DTT) and adsorbed to multiple small aliquots of F3GA
resin (100 lg protein per 10 mg resin) in 2 ml spin-col-
umns (Costar, Fisher Scientiﬁc). Binding was for 1 h at
4C with very gentle vortexing, followed by recovery of
unbound protein (ﬂow-through fraction) and washing of the
resin (4 9 0.4 ml washes with CB); spin-columns were
micro-centrifuged for 30 s at 10,0009g, to recover frac-
tions and change solutions. Individual spin-columns con-
taining resin-bound proteins were then incubated (as for
protein binding, above) with 50 ll 1 mM test ligand in CB,
and the elution fractions recovered by centrifugation.
Protein which remained bound to the resin was recovered
Table 1 Predicted ALDH family proteins in the M. tuberculosis Genome
a
Locus tag Protein name (probable)
b Putative
class
c
Rossmann
motif
d
Rv0147 Aldehyde dehydrogenase (NAD? dependent) ALDH-3 Yes
Rv0223c
e Aldehyde dehydrogenase ALDH-1 or -2 No
Rv0234c Succinate-semialdehyde dehydrogenase gabD1 (NADP? dependent) ALDH-5 No
Rv0458
e Aldehyde dehydrogenase ALDH-1 or -2 Yes
Rv0753c Methylmalonate-semialdehyde dehydrogenase mmsA ALDH-6 Yes
Rv0768 Aldehyde dehydrogenase aldA (NAD? dependent) ALDH-1 or -2 No
Rv1187 Pyrroline-5-carboxylate dehydrogenase rocA ALDH-4 No
Rv1731 Succinate-semialdehyde dehydrogenase gabD2 (NADP? dependent) ALDH-5 Yes
Rv2858c
e Aldehyde dehydrogenase ALDH-1 or -2 No
Rv3293
e Piperideine-6-carboxilic acid dehydrogenase PCD (antiquintin) ALDH-7 No
a Predicted ALDH proteins were identiﬁed based on the presence, and location, of the two ALDH active site signature sequences derived by
Prosite (see Prosite document PDOC00068 and Fig. 5)
b Protein names are from the NCBI database
c Putative class is based on sequence homology to human ALDH proteins (using NCBI Blastp) and on available protein information in the NCBI
EntrezGene database. For nomenclature of ALDH classes see [52]
d Rossmann motif indicates the presence or absence of the GX1–2GXXG sequence typically found in NAD(H)/FAD-binding proteins (see [23])
e Expressed ALDH proteins puriﬁed from Mtb lysates in this study
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123by heating at 95C for 5 min in 100 ll SDS sample buffer,
and centrifugation (resin fraction). Aliquots of initial pro-
tein, spin-column ﬂow-through and eluate fractions were
diluted 1:1 with 29 SDS sample buffer, and loaded in
equal proportion (equivalent to 1 lg input protein) on 15%
gels and stained with silver.
Rv0223c protein–ligand crystallization and data
collection
Crystallization experiments were carried out by the hang-
ing-drop vapor diffusion method [28] at room temperature
(25C) using 24-well plates. Recombinant Rv0223c was
tested for the presence of bound nucleotides (see Supple-
mentary Methods); the results indicated that the protein has
at most 0.1:1 bound NAD or other nucleotide (see Sup-
plementary Fig. 1). Each protein–ligand solution was pre-
pared by mixing protein (0.68 mM in solution of Buffer D)
with the corresponding ligand (20 mM in H2O) at a molar
ratio of 1:2 protein:ligand. The mixtures were incubated at
room temperature for 30 min prior to setting up crystalli-
zation experiments. The ﬁnal concentration of protein in
each protein–ligand mixture was between 0.60 and
0.63 mM. The ligands used were NAD, NADH, NADP,
NADPH, adenosine, AMP, ADP, ATP, GTP, FAD, FMN
and Cibacron Blue F3GA (free dye). Crystals were grown
from drops consisting of 1 ll protein–ligand solution mixed
with 1 ll of reservoir solution against a reservoir containing
0.1 M MES (pH 6.0) and 0.8 M ammonium sulfate, for
3 days at room temperature. For some ligands (e.g. ATP),
the effect of Mg
?? was tested for crystallization, but
without any noticeable effect, crystallization experiments
reported were executed without Mg
??. Native and SeMet
Rv0223c-NAD complex crystals were ﬂash-cooled in liquid
N2 with the addition of 10% glycerol in the crystallization
buffer as cryoprotectant. Three-wavelength selenium multi-
wavelength anomalous dispersion (MAD) data was col-
lected at the beam line 5.0.2 at the Advanced Light Source
(ALS). A native data set at a resolution of 1.8 A ˚ was col-
lected at the beam line 8.2.1 at the ALS. Both data sets were
processed with the HKL2000 program suite [29].
Structure determination and data analysis of Rv0223c
protein–ligand complexes
Initial phasing was carried out with the program SOLVE
[30] using the MAD data set. The resulting experimental
map was density modiﬁed and traced using the program
RESOLVE [31]. The protein model was further improved
and built with the ARP/WARP package [32, 33] against the
1.8 A ˚ native data. Manual model rebuilding was carried out
with programs COOT [34]. The ﬁnal model of this complex
is deposited in the Protein Data Bank (http://www.rcsb.org)
as entry 3B4W, and has R/Rfree values of 0.18/0.20 at a
resolution of 1.8 A ˚, after reﬁnement with the phenix.reﬁne
program from the PHENIX software package [35]. Differ-
ence electron density maps were calculated for each
Rv0223c-ligand complex by reﬁning the structure of the
Rv0223c protein (without ligands or solvent molecules)
against the observed structure factor amplitudes for each
complex. The resulting crystallographic phases were used
to construct an (mFo - DFu)e
iuc difference map [36]. The
LigandFit algorithm for automated ligand-ﬁtting in PHE-
NIX [37] was used to identify the location of the largest
contiguous regions of high density in the difference map. In
this algorithm the contour level for identiﬁcation of con-
tiguous regions of density is set to a level such that the
largest region is approximately the size of the anticipated
ligand. In this way, the location of this largest region gives
an indication of the location of the ligand. The difference
electron density for each complex is shown in the region of
the NAD in the Rv0223c protein-NAD complex and is
displayed with PyMOL [38]. The overall structure com-
parison between Mtb Rv0223c and human mitochondrial
ALDH-2 was performed by the DaliLite program [39].
Results
Sequence similarities of four Mtb ALDHs captured by
dye-ligand chromatography to each other and to human
ALDH proteins
In Table 2, we examine the degree of sequence identity
among these four Mtb ALDHs and their closest human
homologs in more detail. The sequence identities show that
the four Mtb proteins have more sequence homology to
speciﬁc human ALDHs than to each other; for example,
Rv0223c, Rv0458, and Rv2858c show distinctively smaller
e-values and higher percentages of identical residues when
aligned with human ALDH class 1 and 2 protein (than
when they are aligned with other Mtb ALDHs) by the
NCBI Blastp program, and Rv3293 shows the same result
with human ALDH class 7.
Analysis of the speciﬁcity of ligand–protein
interactions with recombinant Rv0223c using
dye-ligand chromatography
We used a modiﬁed version of our dye-resin/ligand-elution
procedure to examine the speciﬁcity of ligand binding of
one of the four Mtb ALDHs (see Materials and Methods).
In this ligand-speciﬁc elution screen, recombinant Rv0223c
was adsorbed on small aliquots of F3GA resin in spin-
columns and assayed for elution by twelve nucleotides and
nucleosides using one ligand per column. By using puriﬁed
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123recombinant protein and one ligand per column, we iden-
tify effects of individual ligands on the stability of the dye-
Rv0223c protein complex. We expect that those ligands
that cause the Rv0223c protein to elute from the resin are
likely to bind speciﬁcally to the protein, although non-
speciﬁc interactions could potentially also cause elution to
occur [24].
Figure 1 shows that the Rv0223c protein was eluted by
NAD and NADH but only weakly by NADP and NADPH.
This result is consistent with the dinucleotide preferences
of homologous NAD-dependent aldehyde dehydrogenases
(E.C. 1.2.1.3) from other organisms [40] and is addressed
further below in the context of structural data. Addition-
ally, the elution of Rv0223c protein by AMP/ADP/ATP is
consistent with adenylate-binding by other dehydrogenases
(cf. [3]).
The differences in the release of Rv0223c from the
afﬁnity resin by various ligands were substantial (Fig. 1),
and the elution of the puriﬁed recombinant Mtb ALDH
with ATP is consistent with the observations from exper-
iments with crude cytosolic extracts (Fig. 1; Table 3 of
[24]. Comparing the methods used for recombinant pro-
teins versus native proteins in cell extracts, we note that the
method for cell extracts has some potential complications.
As cell extracts are mixtures of many proteins of various
abundances, binding and detection of minor proteins may
be difﬁcult. Moreover, some proteins retained on the col-
umn may be bound via other proteins in native complexes,
rather than directly to the dye, while others may have
increased or unchanged afﬁnity for the dye when bound to
ligands [24]. Finally, the order of elution, especially when
several related ligands are used, could potentially inﬂuence
gel spot intensity and identiﬁcation of some proteins due to
depletion by earlier ligand(s). This method is therefore only
useful as a positive screen; any protein eluted by a speciﬁc
ligand is a possible in vivo target of that ligand, whereas
failure to detect a given protein is uninformative. In con-
trast, our analysis of recombinant proteins eliminates most
of these variables, and allows the direct comparison of a
protein’s afﬁnity for an array of ligands at the dye-binding
site.
Overall, Fig. 1 indicates that NAD, NADH, ATP, ADP,
AMP and FAD all interact with Rv0223c protein, and that
the highest afﬁnity is for NADH and ADP. This pattern
was identical in 3 replicate experiments. Further it indi-
cates that NADP, NADPH, adenosine, GTP, FMN, and
NMN interact only weakly with Rv0223c at the dye-
binding site; ligand binding elsewhere in the protein cannot
be ruled out.
Crystallization and X-ray diffraction of Mtb Rv0223c
with multiple ligands
Ligands that bind speciﬁcally to proteins are potentially
useful for protein crystallization and structure determina-
tion [41]. We therefore examined the effects of the
nucleotide/nucleoside ligands shown in Fig. 1 on the
crystallization of recombinant Rv0223c protein. We carried
out a systematic screen for conditions that led to crystal-
lization of Rv0223c in the presence of NAD, and found one
Table 2 Homology analysis of Mtb ALDHs being compared with other Mtb ALDH or Human ALDH by the NCBI Blastp program
Mtb ALDHs Rv0223c Rv0458 Rv2858c Rv3293
e-value
a (seq. id/res)
b e-value (seq. id/res) e-value (seq. id/res) e-value (seq. id/res)
Rv0223c 0 1E-70 (36%/485) 2E-76 (37%/470) 6E-54 (32%/451)
Rv0458 1E-70 (36%/485) 0 9E-69 (35%/466) 7E-38 (26%/471)
Rv2858c 2E-76 (37%/470) 9E-69 (35%/466) 0 5E-51 (33%/441)
Rv3293 6E-54 (32%/451) 7E-38 (26%/471) 5E-51 (33%/441) 0
Hum ALDH1 3E-82 (38%/477) 2E-100 (41%/489) 3E-84 (40%/459) 4E-52 (30%/465)
Hum ALDH2 1E-84 (39%/474) 2E-105 (44%/488) 1E-83 (37%/463) 2E-47 (29%/467)
Hum ALDH3 2E-35 (29%/446) 9E-30 (27%/441) 2E-34 (28%/439) 4E-20 (25%/426)
Hum ALDH4 – 2E-21 (24%/443) 2E-29 (27%/457) 2E-22 (26%/440)
Hum ALDH5 1E-65 (32%/476) 7E-56 (30%/494) 9E-61 (35%/443) 6E-50 (30%/458)
Hum ALDH6 4E-50 (28%/479) 3E-40 (27%/454) 3E-39 (27%/443) 3E-44 (29%/418)
Hum ALDH7 – 4E-32 (24%/484) 9E-42 (28%/446) 3E-125 (49%/469)
Four M. tuberculosis ALDHs are, in general, more similar to their human homologs than to each other
a Expected values (e-values) for each pair were generated by NCBI Blastp, available at http://blast.ncbi.nlm.nih.gov/Blast.cgi, using each Mtb
protein to query either the Mtb genome (upper grid) or human genome (lower grid), without sequence ﬁlters. E values calculations incorporate
identity, similarity and gaps in the sequence alignment, and the distance over which proteins can be aligned. E values closer to 0 indicate higher
homology, and the best matches are indicated in bold-face type
b seq. id/res shows percentage of identical residues from the number of aligned residues between two ALDH genes
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123condition that led to crystals of the Rv0223c?NAD com-
plex diffracting to high resolution (1.8 A ˚; see Materials and
Methods; Table 3). We then carried out crystallization
trials of the puriﬁed protein under this condition, but in the
presence of either no ligand or the various nucleoside
ligands used in the dye-ligand chromatography assay. As
shown in Fig. 2, ligand-free protein generally yielded
either very small or no crystals in repeated tests for crys-
tallization (in one experiment, crystals were obtained that
diffracted to a relatively low resolution of about 3 A ˚). In
contrast, co-crystallization with several ligands (NAD,
NADH, NADP, adenosine, AMP, GTP and FAD) enhanced
protein crystal formation, yielding crystals diffracting to
high resolution suitable for structural analysis. Other
ligands either hardly affected crystallization (NADPH,
ADP and ATP) or promoted precipitation (FMN, and non-
resin-bound F3GA). NMN was not tested. As summarized
in Table 4, (although further screening of crystallization
conditions may be required for the interactions between
Rv0223c and ADP, ATP and F3GA) the strongly inter-
acting ligands (NAD and NADH) enhanced crystal for-
mation, leading to higher resolution data than the
moderately or weakly interacting ligands (AMP, FAD,
adenosine, GTP and NADP).
The structure of the Rv0223c?NAD complex was
determined by MAD phasing at a resolution of 1.8 A ˚ (PDB
ID 3B4W; Table 3). The structures of all the complexes,
Rv0223c?ligand (NADH, AMP, FAD, adenosine, GTP or
Fig. 1 Ligand-speciﬁc elution
chromatography of recombinant
Rv0223c, a putative Mtb
aldehyde dehydrogenase. One-
dimensional SDS–PAGE
analysis of protein added
(Rv0223c), not bound (FT,
ﬂow-through fraction) or
released from Cibacron Blue
F3GA resin by buffer or 12
different ligands shows the
preferential release by NAD,
NADH, ATP, and ADP
Table 3 Data collection and
reﬁnement statistics
a Numbers in parentheses refer
to the highest resolution shells
b Rmerge = RjIobs - Iavgj/RIavg
c Rcryst = RjFo(hkl) - Fc(hkl)j/
RjFo(hkl)j
d Rfree = Rcryst, calculated for
10% randomly selected
reﬂections that are not included
in the reﬁnement
Native MAD
kpeak kinﬂection kremote
Data collection
Space group P43212
Unit cell parameters:
a, b, c (A ˚)
135.111, 135.111, 72.543
Resolution limits (A ˚) 40–1.80
(1.86–1.80)
a
50–1.9
(2.01–1.90)
50–2.1
(2.18–2.10)
50–2.0
(2.07–2.00)
Wavelength (A ˚) 1.0 0.9795 0.9800 0.9184
No. of unique reﬂections: 62,513 52,746 40,408 46,453
Rmerge
b (%) 9.1 (51.0) 9.0 (47.2) 8.6 (46.6) 8.2 (54.8)
Reﬁnement
Resolution limits (A ˚) 40–1.8
Rcryst
c /Rfree
d (%) 16.8/19.6
No. of protein atoms 3,577
No. of solvent atoms 488
No. of hetrogen atoms 54
rmsd bond lengths (A ˚) 0.008
rmsd bond angles () 1.21
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123NADP) were isomorphic with this one, with less than 1%
changes in cell parameters. Consequently, we were able to
use the structure of the Rv0223c protein (without ligand)
from the Rv0223c?NAD complex to calculate phases and
a difference electron density map for each of these struc-
tures (after reﬁnement using the observed structure factors
for each structure) using the diffraction data indicated in
Table 4.
Location of nucleoside ligands in the Rv0223c
structures
The crystals obtained with NAD, and with its reduced form
NADH, were the largest and best-diffracting crystals (res-
olution range 1.8–2.0 A ˚) that we obtained in repeated
experiments, and the ligand was most clearly deﬁned in the
difference electron density maps for these complexes
(Fig. 3) although the crystals could potentially contain
NAD because NADH showed *50% conversion to NAD
after about 3 days in the crystallization condition used.
These data suggest that Rv0223c forms the most well-
deﬁned complexes with NAD and NADH, consistent with
the gene annotation (putative aldehyde dehydrogenase).
Fig. 2 The improvement of Rv0223c (putative aldehyde dehydroge-
nase) crystallization by addition of ligands identiﬁed by ligand-
speciﬁc elution afﬁnity chromatography method. Crystallization
experiments were carried out by the hanging-drop vapor diffusion
method at room temperature (295K) using 24-well plates. Each
protein–ligand solution was prepared by mixing with the correspond-
ing ligand using molar ratio of 1:2 for protein vs. ligand, and
incubated at room temperature for 30 min. In each protein–ligand
mixture, the dilution factor of protein was kept less than 20% using
the proper concentration of each ligand (NAD, NADH, NADP,
adenosine, AMP, GTP and FAD) solution. The crystals were grown
from drops consisting of 1 lL protein–ligand solution mixed with
1 lL of well solution against a reservoir containing 0.1 M MES (pH
6.0), 0.8 M ammonium sulfate, for 3 days at room temperature
Table 4 Summary of ligand elution from dye and co-crystallization
of Rv0223c
Ligands Dye-Rv0223c elution
a Rv0223c co-crystallization
b
NAD ??? ?(1.8–2.0 A ˚)
NADH ???? ?(1.9–2.0 A ˚)
ADP ???? –
ATP ??? –
F3GA ???? Precipitate
AMP ?? ?(2.6 A ˚)
FAD ?? ?(2.5–3.0 A ˚)
Adenosine ?? (2.3–2.6 A ˚)
GTP ?? (2.5–2.9 A ˚)
NADP ?? (2.7–2.8 A ˚)
NADPH ? –
FMN – Precipitate
NMN – N/A
a The estimation of ligand-speciﬁc elution of Rv0223c from Cibacron
Blue F3GA dye resin in Fig. 1; very strong (????), strong (???),
moderate (??), and weak (?)
b The observation for formation of crystals by co-crystallization with
ligands; diffraction data is shown in parenthesis; N/A indicates no
data available
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123The other ligand-Rv0223c protein complexes diffracted
to 2.3–3.0 A ˚, and for GTP, NADP and AMP, the strongest
difference electron density corresponding to a bound ligand
was found at the NAD-binding site (Fig. 3). In the case of
adenosine-Rv0223c co-crystals, the second-largest region
of contiguous density was at the NAD-binding site, but the
density was weak. In a ﬁnal case (FAD), no clear peaks of
difference density were found. The varied electron density
of ligands binding to a common site in Rv0223c suggests
that the conformation of the ligands at this site may vary
and that there may be considerable ﬂexibility in binding at
this site. It seems possible that the ligands that are normally
involved in the function of Rv0223c might bind in a more
speciﬁc fashion than those that are binding adventitiously,
but we cannot be certain, as we do not know the ligand
speciﬁcity of Rv0223c necessary for its function.
These structural studies provide independent evidence
for various protein–ligand interactions detected using dye-
ligand chromatography (Fig. 1). The crystallization data
together with structural and biochemical analyses show
strong and speciﬁc interactions between NAD (or NADH)
and Rv0223c, while weaker interactions were also detected
between Rv0223c and several other purine nucleosides/
nucleotides (adenosine, AMP, GTP, NADP and FAD).
Structural homology between His tagged recombinant
Rv0223c and human mitochondrial ALDH
The structure of Mtb Rv0223c is the ﬁrst reported structure
from the Mtb ALDH family. We compared this structure
with that of its human homologue, NAD-dependent mito-
chondrial ALDH, ALDH-2 (PDB ID 1CW3) [42], using the
DaliLite server [39] to align the structures, as shown in
Fig. 4. The choice of human ALDH-2 for comparison was
based on sequence similarity (Table 2), and because
Rv0223chas generallybeen categorized asa class 2enzyme
[43,44].ThestructureofRv0223ccloselyoverlappedthatof
human ALDH-2, with an overall rmsd of 1.5 A ˚ over 184
residuesincommon.Onlyminorregionsofincongruitywere
found, and these were in peripheral regions of the protein
(Fig. 4).
The orientation of NAD in Rv0223c was similar to
human ALDH-2 (data not shown) [45]. As Perez-Miller
and Hurley described, the adenine ring of NAD as located
in the hydrophobic pocket formed by helices aD and aEi n
the coenzyme domain, with the nicotinamide end facing
and interacting with residues of the catalytic domain. The
amino acid residues within a 5 A ˚ range of the NAD binding
site (residues in red in Fig. 5) were substantially conserved.
Of the 25 residues of Rv0223c ALDH within this range, 14
were identical to those in the human protein. The spatial
locations of all 14 of these conserved residues were very
close in the two structures with rmsd 1.1 A ˚ (versus rmsd
1.5 A ˚ for the structures overall), and had a similar orien-
tation (data not shown), suggesting that these are critical
amino acids for the interaction with NAD.
We noticed that Mtb Rv0223c is a monomer, whereas
human mitochondrial ALDH is an octamer in crystal lat-
tices [42, 45]. Both samples used for structural analysis
were expressed in E. coli, but the Mtb Rv0223c protein has
Fig. 3 Structure of Mtb
Rv0223c with NAD (in center;
resolution range 1.8–2.0 A ˚), and
the difference electron density
map of other nucleoside ligands
that promoted crystallization of
Rv0223c. NADH (resolution
range 1.9–2.0 A ˚), NADP
(2.7–2.8 A ˚), adenosine
(2.3–2.6 A ˚), AMP (2.6 A ˚),
GTP (2.5–2.9 A ˚) and FAD
(2.5–3.0 A ˚) identiﬁed at the
binding site of NAD
298 C.-Y. Kim et al.
123a His-tag at its C-terminus. In the human mitochondrial
ALDH, the C-terminus of the protein is part of the oligo-
merization domain. It is possible that the His-tag of
Rv0223c may interfere with oligomerization. However, gel
ﬁltration chromatography data with His-tagged and non-
tagged Rv0223c proteins indicated that the His-tag does
not inﬂuence the oligomerization state of the protein as
reﬂected in the monomeric elution times of both proteins
from the column (data not shown). It is more likely that the
Rv0223c protein is monomeric for another reason, as the
C-terminal residues of Mtb Rv0223c (Val486, Thr485, and
Tyr484) are on the opposite side of the oligomerization
domain from the side which is involved in monomer–
monomer contacts based on the human ALDH-2 structure
(PDB ID 1CE3). (Note that the His-tag is not visible in the
electron density map and is therefore not shown in Fig. 4).
Sequence homology between Mtb ALDH Rv0223c and
human mitochondrial ALDH
The partial amino acid sequences of Rv0223c and human
mitochondrial ALDH were aligned based on secondary
structure for sequence homology analysis, as shown in
Fig. 5. The full length Mtb and human sequences are
shown (487 and 518 amino acids, respectively), and were
determined by NCBI Blastp to be 39% identical and 53%
similar. The two ALDH signature sequences identiﬁed by
Prosite [46], and including cysteine and glutamic acid
active site residues, were conserved in both proteins and
found at identical locations.
Discussion
The dye-resin chromatography method generates data
about the interaction of protein and speciﬁc nucleoside
ligand(s), and the identiﬁed ligand(s) may help stabilize the
protein and improve the target protein’s crystallization
(Fig. 2). Structural data obtained from such crystals may
also show the interactions of the ligand with the protein. In
conjunction with functional information derived from the
identiﬁcation of ligands, this may help elucidate the bio-
chemical role of the protein. Additionally, since many
Fig. 4 Comparison of crystal structure of Mtb Rv0223c (green) with
NAD (red) against human mitochondria aldehyde dehydrogenase-2
(orange) structure. The homology of two structures is very high with
RMSD value 1.5 A ˚. In Rv0223c structure, the miss-aligned sequences
(in magenta) are minor, consisting of residues; Pro360, Glu361,
Gly362, and Leu363 in the catalytic domain, Asp9, Lys10, and Leu11
in the coenzyme domain, and Gly135, Ser136, Tyr137, Gly138,
Gln139, and Ser140 in the oligomerization domain. The three
domains are sectioned by purple lines. The adenine ring of NAD
(and NADH) is located in the hydrophobic pocket formed by helices
aD( gray) and aE( blue) in the coenzyme domain
Fig. 5 Protein sequence alignment based on secondary structure of
Mtb protein Rv0223c and human ALDH-2. The protein sequence
alignment based on secondary structure of Mtb protein Rv0223c and
human ALDH-2 was obtained using the DaliLite server [39].
Residues within 5 A ˚ of NAD(H) are shown in red. The two ALDH
signature sequences given by Prosite (PDOC00068) are highlighted in
yellow. The identical amino acids between Rv0223c and human
ALDH-2 are indicated with amino acid letter code and the similar
amino acids are marked by ‘?’ in the line labeled with ‘Ident’. The
secondary structure of each protein was indicated based on the
assignment by DSSP program (H, helix; E, extended strand; L, loop
or irregular) [50]
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123drugs are analogues of nucleosides, proteins bound by
nucleoside analogue drugs can be identiﬁed through this
approach as a biomedical application (Fig. 5 of [24].
The native Mtb Rv0223c protein did not crystallize
readily. As shown in Fig. 2, co-crystallization with NAD
and NADH, which showed strong interaction by dye-ligand
chromatography (Fig. 1), greatly improved the crystal
quality and yielded structures of the complexes at resolu-
tions of 1.8–2.0 A ˚ (Fig. 3; Table 3). In contrast, NADP,
adenosine, GTP, AMP and FAD, which showed relatively
weak interactions (Fig. 1), generated lower resolution (2.3
A ˚ or higher) structural data. We note that the ligands ADP
and ATP, which showed strong interactions with Rv0223c,
did not generate crystals (Table 4). Figure 3 reveals that
ligands share a common interaction site within Rv0223c,
and that Rv0223c contains a hydrophobic pocket and
adenine recognition motif (composed of Gln217 and
Glu239) in the coenzyme domain, which is a common
motif for binding adenine-derivative coenzymes [47]. This
information, in combination with our biochemical data on
protein–ligand interactions (Fig. 1) and crystallization data
from protein–ligand mixtures (Fig. 2), supports the con-
clusion that the binding of each ligand to Rv0223c occurs
via contacts of the ligand to both the adenine recognition
motif and hydrophobic pocket. Further, the stability of
different protein–ligand crystals and their quality for high
resolution structure determination depends on the degree of
stabilization of protein by the interaction of the nicotin-
amide moiety of NAD(H) with residues in the catalytic
domain.
A major bottleneck in structural genomics projects is the
production of crystals suitable for analysis by X-ray dif-
fraction. The demonstration in this work that information
on ligands generated by dye-ligand chromatography can be
used to identify ligands binding to nucleoside-binding
proteins and to improve crystallization may be a signiﬁcant
contribution to overcoming this bottleneck.
There are several extensions to our method that we will
make the process higher throughput. Using LC-MS (or LC-
MS-MS) systems to identify native proteins in cell extracts
that are eluted by speciﬁc ligands [48] may allow the
protein identiﬁcation process to be ﬁnished immediately
after the ligand elution. In addition to Cibacron Blue F3GA
dye resin, which was used in our dye-ligand chromatog-
raphy approach, there are several other dye resins which
are known to interact with a speciﬁc group of proteins [49].
These resins may be useful in binding groups of related
proteins in a high throughput manner. The techniques
described here and in Roberts et al. [24] could be applied to
newly sequenced organisms to identify the metabolically
important proteins that interact with nucleoside ligands,
and to complement the annotation of each gene based on
the interacting ligand(s) [51].
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